Last reviewed · How we verify
Doxylamin
At a glance
| Generic name | Doxylamin |
|---|---|
| Sponsor | St. Petersburg Bekhterev Research Psychoneurological Institute |
| Target | Histamine H1 receptor |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease |
| Phase | FDA-approved |
Approved indications
- Allergic conjunctivitis
- Allergic rhinitis
- Common cold
- Dermatographic urticaria
- Influenza-like symptoms
- Itching of skin
- Nasal congestion
- Nasal discharge
- Seasonal allergic rhinitis
- Sneezing
- Urticaria
- Vasomotor rhinitis
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |